Considering that the PDGF/PDGFR system expression in human adults is associated with diseases and also has a significant association with RA, then targeting this PDGF/PDGFR has great potential in the design of combination therapies for RA [10]. This evidence concerns the gene PDGFRB and rheumatoid arthritis.